<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Am Health Drug Benefits</journal-id><journal-id journal-id-type="iso-abbrev">Am Health Drug Benefits</journal-id><journal-id journal-id-type="pmc-domain-id">2442</journal-id><journal-id journal-id-type="pmc-domain">ahdb</journal-id><journal-id journal-id-type="publisher-id">ahdb</journal-id><journal-title-group><journal-title>American Health &amp; Drug Benefits</journal-title></journal-title-group><issn pub-type="ppub">1942-2962</issn><issn pub-type="epub">1942-2970</issn><publisher><publisher-name>Engage Healthcare Communications, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5470245</article-id><article-id pub-id-type="pmcid-ver">PMC5470245.1</article-id><article-id pub-id-type="pmcaid">5470245</article-id><article-id pub-id-type="pmcaiid">5470245</article-id><article-id pub-id-type="pmid">28626504</article-id><article-id pub-id-type="other">ahdb-10-079</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Clinical</subject><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis</article-title><alt-title>Utilization and Costs Associated with Opioid-Induced Constipation</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Olufade</surname><given-names initials="T">Tope</given-names></name><degrees>PhD, MPH</degrees><aff>Director, Health Economics &amp; Outcomes Research, AstraZeneca, Wilmington, DE</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kong</surname><given-names initials="AM">Amanda M.</given-names></name><degrees>MPH</degrees><aff>Research Leader, Truven Health Analytics, an IBM Company, Bethesda, MD</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Princic</surname><given-names initials="N">Nicole</given-names></name><degrees>MS</degrees><aff>Manager Research Analyst, Truven Health Analytics, an IBM Company, Bethesda, MD</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Juneau</surname><given-names initials="P">Paul</given-names></name><degrees>MS</degrees><aff>Senior Statistician, Truven Health Analytics, an IBM Company, Bethesda, MD</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kulkarni</surname><given-names initials="R">Rucha</given-names></name><degrees>MPH</degrees><aff>Research Analyst at the time of this study, Truven Health Analytics, an IBM Company, Bethesda, MD</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="K">Kui</given-names></name><degrees>MD</degrees><aff>Senior Programmer/Analyst, Truven Health Analytics, an IBM Company, Bethesda, MD</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Datto</surname><given-names initials="C">Catherine</given-names></name><degrees>MD, MS</degrees><aff>US Medical Lead, AstraZeneca</aff></contrib></contrib-group><author-notes><fn><p>Portions of this study were presented at ISPOR 21st Annual International Meeting, May 21&#8211;25, 2016, in Washington, DC.</p></fn></author-notes><pub-date pub-type="ppub"><month>4</month><year>2017</year></pub-date><volume>10</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">293979</issue-id><fpage>79</fpage><lpage>86</lpage><history><date date-type="received"><day>17</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>10</day><month>2</month><year>2017</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2017</year></date></event><event event-type="pmc-live"><date><day>16</day><month>06</month><year>2017</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-01-12 08:56:11.000"><day>12</day><month>01</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2017 by Engage Healthcare Communications, LLC</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Engage Healthcare Communications, LLC</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ahdb-10-079.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="ahdb-10-079.pdf"/><abstract><sec id="sec1"><title>Background</title><p>Constipation is a common adverse effect of opioid use and has been associated with increased healthcare utilization and costs among patients receiving opioids for pain management.</p></sec><sec id="sec2"><title>Objective</title><p>To compare the healthcare utilization and costs of Medicaid patients with chronic noncancer pain with and without constipation who were receiving opioids.</p></sec><sec id="sec3"><title>Methods</title><p>This retrospective, claims-based study was conducted using data from the Truven Health MarketScan Medicaid Multi-State database. Patients with no evidence of cancer who initiated opioid therapy between January 1, 2009, and June 30, 2013, were eligible for the study. Patients had to have continuous enrollment in the database in the 6 months before and 12 months after opioid initiation, with no evidence of substance abuse or functional or inflammatory bowel disease. Medical and pharmacy claims during the 12 months after opioid initiation were evaluated for a diagnosis of constipation or for prescription or over-the-counter medications indicative of constipation. All-cause healthcare utilization and costs were measured over the same period and were compared between propensity score&#8211;matched cohorts of patients with evidence of constipation and patients without constipation.</p></sec><sec id="sec4"><title>Results</title><p>Of the 25,744 patients meeting the study inclusion criteria, 2716 (10.5%) had evidence of constipation. After 1:1 propensity score matching, the 2 cohorts had similar demographic and clinical characteristics (ie, mean age, 47 years; 26%&#8211;27% male). During the 12-month follow-up period, healthcare utilization was more frequent among patients with constipation, including inpatient admissions and emergency department visits, than in the matched patients without constipation. The total all-cause mean healthcare costs were substantially higher among the patients with constipation ($28,234; 95% confidence interval [CI], $24,307&#8211;$32,160) than in the patients without constipation ($13,709; 95% CI, $12,618&#8211;$14,801), with a median cost difference of $4166 per patient (<italic toggle="yes">P</italic> &lt;.001).</p></sec><sec id="sec5"><title>Conclusion</title><p>Among Medicaid enrollees who receive opioids for chronic noncancer pain, constipation is associated with increased all-cause healthcare utilization and costs.</p></sec></abstract><kwd-group><kwd>chronic pain</kwd><kwd>constipation</kwd><kwd>costs</kwd><kwd>healthcare utilization</kwd><kwd>Medicaid</kwd><kwd>noncancer pain</kwd><kwd>opioid-induced constipation</kwd><kwd>opioids</kwd><kwd>propensity score matching</kwd><kwd>side effects</kwd></kwd-group><counts><fig-count count="2"/><table-count count="3"/><ref-count count="31"/><page-count count="9"/><word-count count="4154"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>